
Vicky A. Johnson
Examiner (ID: 14814, Phone: (571)272-7106 , Office: P/3656 )
| Most Active Art Unit | 3656 |
| Art Unit(s) | 3656, 3682, 3617 |
| Total Applications | 2307 |
| Issued Applications | 1679 |
| Pending Applications | 145 |
| Abandoned Applications | 512 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19622915
[patent_doc_number] => 12161707
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Vaccines for
[patent_app_type] => utility
[patent_app_number] => 15/693663
[patent_app_country] => US
[patent_app_date] => 2017-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 33
[patent_no_of_words] => 17114
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15693663
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/693663 | Vaccines for | Aug 31, 2017 | Issued |
Array
(
[id] => 12205834
[patent_doc_number] => 20180051061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'Anti-Microbial Peptides and Coatings'
[patent_app_type] => utility
[patent_app_number] => 15/680429
[patent_app_country] => US
[patent_app_date] => 2017-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 27890
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15680429
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/680429 | Anti-microbial peptides and coatings | Aug 17, 2017 | Issued |
Array
(
[id] => 17198654
[patent_doc_number] => 20210338748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => COMPOSITION FOR PREVENTING OR TREATING MENOPAUSE, CONTAINING LACTOBACILLUS INTESTINALIS
[patent_app_type] => utility
[patent_app_number] => 16/324928
[patent_app_country] => US
[patent_app_date] => 2017-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16324928
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/324928 | Composition for preventing or treating menopause, containing | Aug 10, 2017 | Issued |
Array
(
[id] => 16999466
[patent_doc_number] => 11078257
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Recombinant gram negative bacteria and methods of generating and utilizing same
[patent_app_type] => utility
[patent_app_number] => 16/321093
[patent_app_country] => US
[patent_app_date] => 2017-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 30
[patent_no_of_words] => 15584
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321093
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/321093 | Recombinant gram negative bacteria and methods of generating and utilizing same | Jul 27, 2017 | Issued |
Array
(
[id] => 17800183
[patent_doc_number] => 11414464
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Chimeric proteins for inducing immunity towards infection with
[patent_app_type] => utility
[patent_app_number] => 16/319729
[patent_app_country] => US
[patent_app_date] => 2017-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 42799
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16319729
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/319729 | Chimeric proteins for inducing immunity towards infection with | Jul 23, 2017 | Issued |
Array
(
[id] => 12231935
[patent_doc_number] => 20180064798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'VACCINES FOR PREVENTION AND TREATMENT OF TUBERCULOSIS'
[patent_app_type] => utility
[patent_app_number] => 15/645760
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10885
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645760
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645760 | VACCINES FOR PREVENTION AND TREATMENT OF TUBERCULOSIS | Jul 9, 2017 | Abandoned |
Array
(
[id] => 15052337
[patent_doc_number] => 10456444
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Pirin polypeptide and immune modulation
[patent_app_type] => utility
[patent_app_number] => 15/631952
[patent_app_country] => US
[patent_app_date] => 2017-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 37062
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15631952
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/631952 | Pirin polypeptide and immune modulation | Jun 22, 2017 | Issued |
Array
(
[id] => 11992493
[patent_doc_number] => 20170296645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'Immunogenic Proteins and Compositions'
[patent_app_type] => utility
[patent_app_number] => 15/630679
[patent_app_country] => US
[patent_app_date] => 2017-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 60079
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15630679
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/630679 | Immunogenic proteins and compositions | Jun 21, 2017 | Issued |
Array
(
[id] => 16267380
[patent_doc_number] => 20200268867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => BIOFILM MATRIX-BOOSTED VACCINE
[patent_app_type] => utility
[patent_app_number] => 16/310544
[patent_app_country] => US
[patent_app_date] => 2017-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/310544 | Biofilm matrix-boosted vaccine | Jun 15, 2017 | Issued |
Array
(
[id] => 15678419
[patent_doc_number] => 20200093873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => USE OF LACTIC ACID BACTERIA TO TREAT OR PREVENT GESTATIONAL DIABETES MELLITUS
[patent_app_type] => utility
[patent_app_number] => 16/472071
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472071
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/472071 | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus | Jun 1, 2017 | Issued |
Array
(
[id] => 17060137
[patent_doc_number] => 11104724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Compositions and methods for antibodies targeting staphylococcal leukotoxins
[patent_app_type] => utility
[patent_app_number] => 16/303666
[patent_app_country] => US
[patent_app_date] => 2017-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 67414
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 374
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303666
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/303666 | Compositions and methods for antibodies targeting staphylococcal leukotoxins | May 22, 2017 | Issued |
Array
(
[id] => 12057198
[patent_doc_number] => 20170333543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'ATTENUATED BURKHOLDERIA MALLEI STRAIN WHICH PROTECTS AGAINST PATHOGENIC BURKHOLDERIA INFECTIONS, VACCINE CONTAINING AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/598787
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 12401
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15598787
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/598787 | Attenuated | May 17, 2017 | Issued |
Array
(
[id] => 16290320
[patent_doc_number] => 10767157
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Devices, systems and methods for the production of humanized gut commensal microbiota
[patent_app_type] => utility
[patent_app_number] => 15/598488
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 17356
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15598488
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/598488 | Devices, systems and methods for the production of humanized gut commensal microbiota | May 17, 2017 | Issued |
Array
(
[id] => 12058650
[patent_doc_number] => 20170334994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CLOSTRIDIUM DIFFICILE INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/597384
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 28217
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15597384
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/597384 | Compositions and methods for treating | May 16, 2017 | Issued |
Array
(
[id] => 16040165
[patent_doc_number] => 10681932
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Specific bacteria for their use as a medicament, in particular for controlling excess weight, obesity, cardiometabolic diseases and inflammatory bowel diseases
[patent_app_type] => utility
[patent_app_number] => 15/591389
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6920
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15591389
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/591389 | Specific bacteria for their use as a medicament, in particular for controlling excess weight, obesity, cardiometabolic diseases and inflammatory bowel diseases | May 9, 2017 | Issued |
Array
(
[id] => 12049879
[patent_doc_number] => 20170326222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'NON-LIPIDATED VARIANTS OF NEISSERIA MENINGITIDIS ORF2086 ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 15/587574
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 29285
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15587574
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/587574 | Non-lipidated variants of | May 4, 2017 | Issued |
Array
(
[id] => 14357785
[patent_doc_number] => 10300173
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Compounds and methods for biofilm disruption and prevention
[patent_app_type] => utility
[patent_app_number] => 15/586443
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12622
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586443
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/586443 | Compounds and methods for biofilm disruption and prevention | May 3, 2017 | Issued |
Array
(
[id] => 12976081
[patent_doc_number] => 20170340779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => Compounds and Methods for Biofilm Disruption and Prevention
[patent_app_type] => utility
[patent_app_number] => 15/586738
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586738
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/586738 | Compounds and Methods for Biofilm Disruption and Prevention | May 3, 2017 | Abandoned |
Array
(
[id] => 12029572
[patent_doc_number] => 20170319671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'YEAST VACCINE VECTOR INCLUDING IMMUNOSTIMULATORY AND ANTIGENIC POLYPEPTIDES AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/585488
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9413
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15585488
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/585488 | Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same | May 2, 2017 | Issued |
Array
(
[id] => 13248947
[patent_doc_number] => 10137145
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified
[patent_app_type] => utility
[patent_app_number] => 15/584619
[patent_app_country] => US
[patent_app_date] => 2017-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22966
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15584619
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/584619 | Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified | May 1, 2017 | Issued |